BSE filing, NSE: MUDUNURU. Summary written from the filing by ALFA Finder's alert engine.
Mudunuru Ltd: key numbers
- Share price
- ₹7.15
- Market cap
- ₹23.39 Cr
- Revenue (annual)
- ₹3.19 Cr
- Net profit (annual)
- ₹-1.80 Cr
- P/E (TTM)
- -12.2×Sector 23.0×
- Promoter holding
- 52.53%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mudunuru Ltd
All →Mudunuru Annual General Meeting
Mudunuru Limited held its 32nd Annual General Meeting on 30.09.2026, where shareholders approved the adoption of accounts and the re-appointment of directors.
Mudunuru Annual General Meeting
Mudunuru Ltd has issued the notice for its 32nd Annual General Meeting scheduled for September 30, 2026, to discuss annual accounts and director re-appointment.
Mudunuru Management Change
Mudunuru Ltd announced the re-appointment of M/s. Nanduri & Associates as Internal Auditor and Mrs. Ragasita Manjari Thummalapalli as Executive Director.
Mudunuru Board Meeting Outcome
Mudunuru Ltd announced the appointment of internal auditors, the re-appointment of an Executive Director, and the schedule for its upcoming Annual General Meeting.
Mudunuru Promoter Buying
Promoter Kiran Thummalapalli acquired 16,654 shares of Mudunuru Limited via open market purchase. This transaction increased the promoter's stake by 0.06% to 6.85%.
Mudunuru Capital Structure Change
Director Kiran Thummalapalli acquired 16,654 equity shares of Mudunuru Ltd via market purchase for ₹0.01 Crore, increasing their stake to 6.85%.
- Value
- ₹0.01 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.